Tower Research Capital (TRC)’s ZyVersa Therapeutics ZVSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-4,525
| Closed | -$3.06K | – | 5690 |
|
|
2025
Q2 | $3.06K | Buy |
4,525
+2,370
| +110% | +$1.55K | ﹤0.01% | 4556 |
|
|
2025
Q1 | $1.35K | Sell |
2,155
-1,328
| -38% | -$1.5K | ﹤0.01% | 4728 |
|
|
2024
Q4 | $3.69K | Buy |
3,483
+917
| +36% | +$1.45K | ﹤0.01% | 4614 |
|
|
2024
Q3 | $6.16K | Buy |
2,566
+1,867
| +267% | +$5.99K | ﹤0.01% | 4174 |
|
|
2024
Q2 | $2.63K | Sell |
699
-155
| -18% | -$831 | ﹤0.01% | 4981 |
|
|
2024
Q1 | $6.41K | Buy |
854
+456
| +115% | +$3.44K | ﹤0.01% | 4376 |
|
|
2023
Q4 | $3.58K | Buy |
398
+382
| +2,388% | +$10.7K | ﹤0.01% | 5058 |
|
|
2023
Q3 | $750 | Hold |
16
| – | – | ﹤0.01% | 5482 |
|
|
2023
Q2 | $1.41K | Buy |
16
+3
| +23% | +$787 | ﹤0.01% | 5381 |
|
|
2023
Q1 | $9K | Buy |
+13
| New | +$9.72K | ﹤0.01% | 4554 |
|